Viewing Study NCT02596256


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2026-01-18 @ 12:34 AM
Study NCT ID: NCT02596256
Status: UNKNOWN
Last Update Posted: 2018-04-17
First Post: 2015-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Plus Docetaxel Versus Docetaxel as Second-line Treatment in Advanced Gastric Cancer (AHEAD-301)
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module